SU2C’s Innovative Research Grants (IRGs) support cutting-edge cancer research that might not receive funding through traditional channels. IRGs provide significant funding to early-career scientists with novel ideas that have a strong potential to impact patient care.
Each award provides $750,000 over three years. Since 2009, 46 awards have been made to date in four classes.